Characterization of the SARS‐CoV ‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors-Reference-Cited by-同舟云学术

Characterization of the SARS‐CoV ‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors

Published:2021-04-13 Issue:6 Volume:30 Page:1114-1130
ISSN:0961-8368
Container-title:Protein Science
language:en
Short-container-title:Protein Science

Author:

Cao Yipeng¹²^ORCID,Yang Rui³,Lee Imshik⁴,Zhang Wenwen¹,Sun Jiana¹,Wang Wei¹^ORCID,Meng Xiangfei²

Affiliation:

1. Tianjin Medical University Cancer Institute and Hospital Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer Tianjin People's Republic of China

2. National Supercomputer Center in Tianjin TEDA‐Tianjin Economic‐Technological Development Area Tianjin People's Republic of China

3. Department of Infection and Immunity Tianjin Union Medical Center, Nankai University Affiliated Hospital Tianjin People's Republic of China

4. College of Physics Nankai University Tianjin People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pro.4075

Reference152 articles.

1. Real estimates of mortality following COVID-19 infection

2. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

3. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

4. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

5. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral effect of the viroporin inhibitors against Taiwan isolates of infectious bronchitis virus (IBV);Virus Research;2024-11

2. Natural antiretroviral compounds as the inhibitors of the SARS-CoV-2 M protein;Journal of Molecular Liquids;2024-10

3. Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection;2024-09-13

4. Immunogenicity and Protective Efficacy of Baculovirus-Expressed SARS-CoV-2 Envelope Protein in Mice as a Universal Vaccine Candidate;Vaccines;2024-08-28

5. Membrane Activity and Viroporin Assembly for the SARS-CoV-2 E Protein Are Regulated by Cholesterol;Biomolecules;2024-08-26